Journalartikel

Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?


AutorenlisteAlm, Julia; Duong, Yalin; Wienzek-Lischka, Sandra; Cooper, Nina; Santoso, Sentot; Sachs, Ulrich J.; Kiefel, Volker; Bein, Gregor

Jahr der Veröffentlichung2022

Seiten14-23

ZeitschriftBritish Journal of Haematology

Bandnummer198

Heftnummer1

ISSN0007-1048

eISSN1365-2141

Open Access StatusHybrid

DOI Linkhttps://doi.org/10.1111/bjh.18173

VerlagWiley


Abstract
Most cases of fetal and neonatal thrombocytopenia (FNAIT) are caused by maternal anti-human platelet antigen-1a antibodies (anti-HPA-1a). Anti-HPA-5b antibodies are the second most common antibodies in suspected FNAIT cases. Given the high prevalence of anti-HPA-5b antibodies in pregnant women delivering healthy newborns, the association with FNAIT may be coincidental. This review of the literature related to FNAIT using the MEDLINE database was conducted according to PRISMA guidelines. A retrospective analysis of a single-centre cohort of 817 suspected FNAIT cases was conducted. The pooled prevalence of anti-HPA-5b antibodies in unselected pregnant women of European descent was 1.96% (n = 3113), compared with 3.4% (n = 5003) in women with suspected FNAIT. We found weak evidence that a small proportion of pregnant women presenting with anti-HPA-5b antibodies will give birth to a newborn with mild thrombocytopenia. The neonatal platelet counts were not different between suspected FNAIT cases (n = 817) with and without maternal anti-HPA-5b antibodies. The prevalence of maternal anti-HPA-5b antibodies was not different between neonates with intracranial haemorrhage and healthy controls. The current experimental and epidemiological evidence does not support the hypothesis that anti-HPA-5b antibodies cause severe thrombocytopenia or bleeding complications in the fetus or newborn.



Zitierstile

Harvard-ZitierstilAlm, J., Duong, Y., Wienzek-Lischka, S., Cooper, N., Santoso, S., Sachs, U., et al. (2022) Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?, British Journal of Haematology, 198(1), pp. 14-23. https://doi.org/10.1111/bjh.18173

APA-ZitierstilAlm, J., Duong, Y., Wienzek-Lischka, S., Cooper, N., Santoso, S., Sachs, U., Kiefel, V., & Bein, G. (2022). Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?. British Journal of Haematology. 198(1), 14-23. https://doi.org/10.1111/bjh.18173



Schlagwörter


ALLOANTIBODIESALLOANTIGEN SYSTEMALPHA-2-BETA-1anti-HPA-5bAUTOANTIBODIESfetal and neonatal alloimmune thrombocytopeniafetal medicineIMMUNOLOGICAL ANALYSISMAIPAPOSTTRANSFUSION PURPURATRANSFUSION


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 11:38